Home / Drug shortages / Dexamethasone Sodium Phosphate Injection

Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 02/08/2019.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6146-25
Dosage Form
Injection
Presentation
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)
Initial Posting
02/08/2019
Revised Date

FDA data resources